LRP Platform

The ability to target therapeutics to the organs and to balance the exposure at the site of action against other compartments of the body can often not be guaranteed.

Technologies for direct organ delivery are limited by safety, procedural complexity, or inability to achieve homogenous organ exposure.

High potency therapeutics often need to achieve high local levels of drug throughout the tissue which is limited by mode of delivery.

Advanced medicines are often given to patients with multiple comorbidities which increases the risk of systemic exposure.